Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This trial is going to evaluate the safety and effectiveness of intranasal
DEX(dexmedetomidine) in breast lumpectomy under local anaesthesia,and to investigate the
optimal dose of intranasal DEX in breast lumpectomy.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital